Skip to main content
. 2013 May 20;1(4):643–648. doi: 10.3892/mco.2013.126

Figure 2.

Figure 2

The 5-year disease-specific survival rate for the group of patients with ≥4 micrometastases was significantly lower compared to that for the group with 0–3 micrometastases (46 vs. 92%, P<0.01).